Biocon Ltd
NSE: BIOCON BSE: 532523
₹368.55
(-1.01)%
Thu, 05 Feb 2026, 03:01 am
Market Cap602.8B
PE Ratio92.82
Dividend0.13
Health Technology
Pharmaceuticals: Major
24.5KFinancials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.89B | 9.86B | 10.54B | 16.09B | 23.68B | 27.71B | 20.49B | 24.26B | 28.51B | 30.59B | 33.47B | 38.91B | 40.32B | 54.55B | 62.32B | 71.33B | 81.84B | 110.74B | 147.03B | 152.11B |
| Gross profit | 2.46B | 3.42B | 3.77B | 4.50B | 5.47B | 6.36B | 6.16B | 6.45B | 7.05B | 7.61B | 8.37B | 10.47B | 9.57B | 13.19B | 16.26B | 20.89B | 24.68B | 34.29B | 45.94B | 41.55B |
| Operating expenses (excl. COGS) | -90.99M | -1.36B | -1.77B | -2.27B | -2.06B | -2.27B | -3.10B | -3.13B | -3.92B | -4.29B | -4.29B | -4.58B | -5.91B | -4.16B | -6.26B | -11.27B | -12.62B | -14.76B | -19.62B | -25.07B |
| Selling/general/admin expenses, total | — | -1.35B | -1.76B | -2.25B | -2.03B | -2.23B | -3.05B | -3.02B | -3.77B | -4.08B | -4.29B | -4.58B | -5.91B | -4.16B | -7.47B | -11.27B | -12.62B | -14.76B | -19.62B | -25.07B |
| Research & development | -411.31M | -309.99M | -501.97M | -489.84M | -330.34M | -650.20M | -817.00M | -1.62B | -944.00M | -1.08B | -1.48B | -1.36B | -2.16B | -3.02B | -4.50B | -4.69B | -6.18B | -11.19B | -11.28B | -8.79B |
| Selling/general/admin expenses, other | — | -1.04B | -1.25B | -1.76B | -1.70B | -1.58B | -2.23B | -1.40B | -2.83B | -3.01B | -2.80B | -3.22B | -3.75B | -1.13B | -2.98B | -6.58B | -6.44B | -3.57B | -8.34B | -16.28B |
| Other operating expenses, total | -90.99M | -10.75M | -10.85M | -18.98M | -24.91M | -38.00M | -53.00M | -105.00M | -146.00M | -202.00M | 0 | 0 | 0 | 0 | 1.21B | 0 | 0 | 0 | 0 | 0 |
| Operating income | 1.96B | 2.06B | 2.00B | 2.23B | 3.42B | 4.09B | 3.05B | 3.32B | 3.13B | 3.32B | 4.08B | 5.89B | 3.66B | 9.04B | 9.99B | 9.63B | 12.06B | 19.53B | 26.31B | 16.48B |
| Non-operating income, total | 59.17M | 37.57M | 290.85M | 355.60M | 99.25M | 379.70M | 871.00M | 2.78B | 2.25B | 2.92B | 3.22B | 2.44B | 2.22B | 3.10B | 2.15B | 1.84B | -164.00M | -8.89B | -10.22B | 2.38B |
| Interest expense, net of interest capitalized | -17.59M | -98.75M | -101.80M | -176.62M | -168.92M | -239.39M | -122.00M | -81.00M | -17.00M | -89.00M | -293.00M | -260.00M | -657.00M | -705.00M | -649.00M | -577.00M | -676.00M | -4.19B | -9.74B | -8.97B |
| Interest capitalized | 0 | 0 | 1.02M | 43.18M | 9.60M | 0 | 0 | 0 | 132.00M | 133.00M | 332.00M | — | 67.00M | 94.00M | 545.00M | 857.00M | 1.61B | 2.43B | 4.72B | 5.88B |
| Non-operating income, excl. interest expenses | 76.76M | 136.32M | 379.40M | 532.21M | 268.17M | 619.09M | 993.00M | 846.00M | 2.27B | 3.23B | 1.91B | 2.57B | 2.82B | 3.84B | 2.13B | 669.00M | 1.61B | 719.00M | 7.28B | 11.89B |
| Non-operating interest income | 10.36M | 1.19M | 0 | 1.43M | 2.06M | 10.14M | 52.00M | 98.00M | 113.00M | 120.00M | 428.00M | 1.11B | 427.00M | 908.00M | 824.00M | 770.00M | 1.12B | 1.12B | 1.61B | 1.09B |
| Miscellaneous non-operating expense | 66.40M | 135.13M | 379.40M | 530.79M | 266.10M | 608.95M | 941.00M | 748.00M | 2.15B | 3.11B | 1.48B | 1.45B | 2.40B | 2.93B | 1.31B | -101.00M | 489.00M | -405.00M | 5.66B | 10.81B |
| Unusual income/expense | — | — | 13.26M | — | — | — | — | 2.02B | — | -218.00M | 1.61B | 132.00M | 58.00M | -31.00M | 673.00M | 1.75B | -1.10B | -5.42B | -7.75B | -536.00M |
| Pretax income | 2.02B | 2.10B | 2.29B | 2.58B | 3.51B | 4.47B | 3.92B | 6.10B | 5.38B | 6.24B | 7.30B | 8.33B | 5.89B | 12.14B | 12.15B | 11.47B | 11.90B | 10.64B | 16.09B | 18.87B |
| Taxes | -299.80M | -158.43M | -113.82M | -99.16M | -486.68M | -721.21M | -541.00M | -975.00M | -1.07B | -957.00M | -1.42B | -1.62B | -1.57B | -2.12B | -3.15B | -2.21B | -2.12B | -2.54B | -2.27B | -4.57B |
| Non-controlling/minority interest | 19.69M | 61.77M | 65.23M | -71.31M | -95.62M | -75.33M | 0 | -38.00M | -170.00M | -310.00M | -587.00M | -760.00M | -807.00M | -973.00M | -1.23B | -1.06B | -1.23B | -1.80B | -2.75B | -4.16B |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.74B | 2.00B | 2.25B | 2.40B | 2.93B | 3.68B | 3.38B | 5.09B | 4.14B | 4.97B | 5.50B | 6.12B | 3.72B | 9.05B | 7.77B | 7.41B | 6.48B | 4.63B | 10.22B | 10.13B |
| Net income | 1.74B | 2.00B | 2.25B | 2.40B | 2.93B | 3.68B | 3.42B | 5.09B | 4.14B | 4.97B | 5.50B | 6.12B | 3.72B | 9.05B | 7.48B | 7.41B | 6.48B | 4.63B | 10.22B | 10.13B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.74B | 2.00B | 2.25B | 2.40B | 2.93B | 3.68B | 3.42B | 5.09B | 4.14B | 4.97B | 5.50B | 6.12B | 3.72B | 9.05B | 7.48B | 7.41B | 6.48B | 4.63B | 10.22B | 10.13B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.26B | 2.73B | 2.94B | 3.33B | 4.82B | 5.66B | 4.80B | 5.11B | 5.16B | 5.53B | 6.57B | 8.67B | 7.51B | 13.52B | 15.52B | 16.78B | 20.21B | 30.66B | 42.00B | 33.35B |
| EBIT | 1.96B | 2.06B | 2.00B | 2.23B | 3.42B | 4.09B | 3.05B | 3.32B | 3.13B | 3.32B | 4.08B | 5.89B | 3.66B | 9.04B | 9.99B | 9.63B | 12.06B | 19.53B | 26.31B | 16.48B |
| Total operating expenses | -5.93B | -7.80B | -8.53B | -13.86B | -20.26B | -23.62B | -17.44B | -20.95B | -25.39B | -27.27B | -29.40B | -33.02B | -36.65B | -45.51B | -52.33B | -61.71B | -69.78B | -91.22B | -120.72B | -135.63B |
| Prepaid expenses | — | 35.30M | 207.80M | 218.00M | 198.93M | 266.33M | 104.00M | 131.00M | 201.00M | 561.00M | 666.00M | 1.35B | 823.00M | 1.02B | 689.00M | 705.00M | 873.00M | 1.32B | 1.57B | 1.90B |
| Deferred income, current | — | — | — | — | — | 5.11B | 1.12B | 1.42B | 2.68B | 3.37B | 2.69B | 2.61B | 2.73B | 3.12B | 4.12B | 5.04B | 5.50B | 7.32B | 6.34B | 7.57B |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 167.00M | 160.00M | 1.14B | 2.21B | 2.21B | 2.09B | 4.92B | 5.39B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 325.44M | 448.31M | 464.98M | 466.25M | 508.31M | 496.76M | 494.00M | 485.00M | 540.00M | 540.00M | 686.00M | 916.00M | 1.02B | 1.17B | 298.00M | 323.00M | 523.00M | 3.82B | 3.92B | 3.58B |
| Deferred income, non-current | 0 | — | — | — | — | — | 5.39B | 3.36B | 4.26B | 2.84B | 3.71B | 3.52B | 3.42B | 8.05B | 9.49B | 10.25B | 12.15B | 2.90B | 3.11B | 3.37B |
| Minority interest | 32.22M | -7.99M | -73.22M | 247.69M | 337.90M | 377.30M | 38.00M | 653.00M | 823.00M | 1.72B | 2.66B | 3.76B | 4.68B | 6.09B | 6.77B | 8.81B | 10.38B | 46.22B | 54.91B | 60.69B |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -199.28M | -250.00M | -300.00M | -500.00M | -600.00M | -700.00M | -900.00M | -1.00B | -1.50B | -1.45B | -2.20B | 0 | -787.00M | -793.00M | -701.00M | 0 | 0 | -718.00M | -2.03B | -829.00M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800